Home
Issues
Aim & Scope
Open Access
Indexing
Why publish with us
Contact
Editorial Board
Instructions to Authors (PDF)
Manuscript Types
Manuscript Formatting
How to submit
Preprints
Authorship & COI
Principles of Transparency Checklist
Publication Ethics and Publication Malpractice Statement
Data Policies
EDITORIAL
Non Tuberculous Mycobacterial Infection From Oscar Wilde to Gene Sequencing
1
First Academic Department of Pneumonology, Interstitial Lung Diseases Unit, Hospital for Diseases of the Chest, “Sotiria”, Medical School, National and Kapodistrian University of Athens, Athens, Greece
Corresponding author
Argyrios Tzouvelekis
First Academic Department of Pneumonology Hospital for Diseases of the Chest, “Sotiria” 152 Messogion Avenue, 11527, Athens, Greece
First Academic Department of Pneumonology Hospital for Diseases of the Chest, “Sotiria” 152 Messogion Avenue, 11527, Athens, Greece
Pneumon 2018;31(1):11–13
KEYWORDS
REFERENCES (10)
1.
Griffith DE, Aksamit T, Brown-Elliott BA, et al. An official ATS/ IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007; 175:367-416.
3.
Donatelli C, Mehta AC. Lady Windermere syndrome: Mycobacterium of sophistication. Cleve Clin J Med 2015; 82:641-3.
4.
Ryu YJ, Koh WJ, Daley CL. Diagnosis and Treatment of Nontuberculous Mycobacterial Lung Disease: Clinicians’ Perspectives. Tuberc Respir Dis (Seoul) 2016; 79:74-84.
5.
Philley JV, Wallace RJ, Jr., Benwill JL, et al. Preliminary Results of Bedaquiline as Salvage Therapy for Patients With Nontuberculous Mycobacterial Lung Disease. Chest 2015; 148:499-506.
6.
Peloquin C. The Role of Therapeutic Drug Monitoring in Mycobacterial Infections. Microbiol Spectr 2017; 5(1): doi: 10.1128/ microbiolspec. TNMI7-0029-2016.
7.
Egelund EF, Fennelly KP, Peloquin CA. Medications and monitoring in nontuberculous mycobacteria infections. Clin Chest Med 2015; 36:55-66.
8.
Cowman S, Burns K, Benson S, Wilson R, Loebinger MR. The antimicrobial susceptibility of non-tuberculous mycobacteria. J Infect 2016; 72:324-31.
9.
Wallace RJ, Jr., Brown-Elliott BA, Crist CJ, Mann L, Wilson RW. Comparison of the in vitro activity of the glycylcycline tigecycline (formerly GAR-936) with those of tetracycline, minocycline, and doxycycline against isolates of nontuberculous mycobacteria. Antimicrob Agents Chemother 2002; 46:3164-7.
10.
Mitchell JD. Surgical approach to pulmonary nontuberculous mycobacterial infections. Clin Chest Med 2015; 36:117-22.
Share
RELATED ARTICLE
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.